Crystal structure of the human σ1 receptor

[1]  Deo R. Singh,et al.  The sigma-1 receptors are present in monomeric and oligomeric forms in living cells in the presence and absence of ligands. , 2015, The Biochemical journal.

[2]  T. Mavlyutov,et al.  Role of the Sigma-1 receptor in Amyotrophic Lateral Sclerosis (ALS) , 2015, Journal of pharmacological sciences.

[3]  K. Fukunaga,et al.  Methyl pyruvate rescues mitochondrial damage caused by SIGMAR1 mutation related to amyotrophic lateral sclerosis. , 2014, Biochimica et biophysica acta.

[4]  Dennis K. Miller,et al.  Relationship between Cerebral Sigma-1 Receptor Occupancy and Attenuation of Cocaine’s Motor Stimulatory Effects in Mice by PD144418 , 2014, The Journal of Pharmacology and Experimental Therapeutics.

[5]  B. Fox,et al.  The Oligomeric States of the Purified Sigma-1 Receptor Are Stabilized by Ligands , 2014, The Journal of Biological Chemistry.

[6]  Piotr Sliz,et al.  Collaboration gets the most out of software , 2013, eLife.

[7]  T. Mavlyutov,et al.  Lack of sigma-1 receptor exacerbates ALS progression in mice , 2013, Neuroscience.

[8]  P. Zwart,et al.  Towards automated crystallographic structure refinement with phenix.refine , 2012, Acta crystallographica. Section D, Biological crystallography.

[9]  F. Al-Mohanna,et al.  A mutation in sigma‐1 receptor causes juvenile amyotrophic lateral sclerosis , 2011, Annals of neurology.

[10]  Hyeon Joo,et al.  OPM database and PPM web server: resources for positioning of proteins in membranes , 2011, Nucleic Acids Res..

[11]  S. Buch,et al.  The sigma-1 receptor chaperone as an inter-organelle signaling modulator. , 2010, Trends in pharmacological sciences.

[12]  S. Rasmussen,et al.  Structure of a nanobody-stabilized active state of the β2 adrenoceptor , 2010, Nature.

[13]  Tal Pupko,et al.  ConSurf 2010: calculating evolutionary conservation in sequence and structure of proteins and nucleic acids , 2010, Nucleic Acids Res..

[14]  Liisa Holm,et al.  Dali server: conservation mapping in 3D , 2010, Nucleic Acids Res..

[15]  G. Pasternak,et al.  σ1 Receptor Modulation of G-Protein-Coupled Receptor Signaling: Potentiation of Opioid Transduction Independent from Receptor Binding , 2010, Molecular Pharmacology.

[16]  Vincent B. Chen,et al.  MolProbity: all-atom structure validation for macromolecular crystallography , 2009, Acta crystallographica. Section D, Biological crystallography.

[17]  Tangui Maurice,et al.  The pharmacology of sigma-1 receptors. , 2009, Pharmacology & therapeutics.

[18]  J. Entrena,et al.  Pharmacology and Therapeutic Potential of Sigma1 Receptor Ligands , 2008, Current neuropharmacology.

[19]  W. Bowen,et al.  Role of Sigma-1 Receptor C-terminal Segment in Inositol 1,4,5-Trisphosphate Receptor Activation , 2008, Journal of Biological Chemistry.

[20]  Teruo Hayashi,et al.  Sigma-1 Receptor Chaperones at the ER- Mitochondrion Interface Regulate Ca2+ Signaling and Cell Survival , 2007, Cell.

[21]  Seung Woo Shin,et al.  Dextromethorphan attenuates trimethyltin-induced neurotoxicity via σ1 receptor activation in rats , 2007, Neurochemistry International.

[22]  V. Reisinger,et al.  Analysis of Membrane Protein Complexes by Blue Native PAGE , 2006, Proteomics.

[23]  Axel T Brunger,et al.  Refractive index‐based determination of detergent concentration and its application to the study of membrane proteins , 2005, Protein science : a publication of the Protein Society.

[24]  G. Debonnel,et al.  Distinct modulatory roles of sigma receptor subtypes on glutamatergic responses in the dorsal hippocampus , 2005, Synapse.

[25]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[26]  J. Cedarbaum.  Survival , 2004 .

[27]  G Bricogne,et al.  Generation, representation and flow of phase information in structure determination: recent developments in and around SHARP 2.0. , 2003, Acta crystallographica. Section D, Biological crystallography.

[28]  Meyer B. Jackson,et al.  The Sigma Receptor as a Ligand-Regulated Auxiliary Potassium Channel Subunit , 2002, Neuron.

[29]  G. Pasternak,et al.  Sigma1 receptor modulation of opioid analgesia in the mouse. , 2002, The Journal of pharmacology and experimental therapeutics.

[30]  P. Casellas,et al.  Expression pattern of the type 1 sigma receptor in the brain and identity of critical anionic amino acid residues in the ligand-binding domain of the receptor. , 2001, Biochimica et biophysica acta.

[31]  B. Roth,et al.  The Multiplicity of Serotonin Receptors: Uselessly Diverse Molecules or an Embarrassment of Riches? , 2000 .

[32]  P. Casellas,et al.  Colocalization of sterol isomerase and sigma(1) receptor at endoplasmic reticulum and nuclear envelope level. , 1999, European journal of biochemistry.

[33]  S. Okuyama,et al.  Amino acid residues in the transmembrane domain of the type 1 sigma receptor critical for ligand binding , 1999, FEBS letters.

[34]  K. Kovács,et al.  Up-regulation of [3H]DTG but not [3H](+)-pentazocine labeled sigma sites in mouse spinal cord by chronic morphine treatment. , 1998, European journal of pharmacology.

[35]  T. Heffner,et al.  The Pharmacology of the Novel and Selective Sigma Ligand, PD 144418 , 1997, Neuropharmacology.

[36]  E. Kempner,et al.  Purification, molecular cloning, and expression of the mammalian sigma1-binding site. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[37]  W. Bowen,et al.  Synthesis and characterization of [125I]-N-(N-benzylpiperidin-4-yl)-4- iodobenzamide, a new sigma receptor radiopharmaceutical: high-affinity binding to MCF-7 breast tumor cells. , 1994, Journal of medicinal chemistry.

[38]  M. Brownstein.  A brief history of opiates, opioid peptides, and opioid receptors. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[39]  S. Snyder,et al.  Structural determinants of sigma receptor affinity. , 1987, Molecular pharmacology.

[40]  J. Thompson,et al.  The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog. , 1976, The Journal of pharmacology and experimental therapeutics.

[41]  B. Lucke-Wold,et al.  Role of sigma-1 receptors in neurodegenerative diseases. , 2015, Journal of pharmacological sciences.

[42]  V. Cherezov,et al.  Crystallizing membrane proteins using lipidic mesophases , 2009, Nature Protocols.

[43]  Teruo Hayashi,et al.  Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival. , 2007, Cell.

[44]  W. Delano.  The PyMOL Molecular Graphics System , 2002 .